* Anemia Pivotal PIII trials - results expected by end of 2008 RPRX - Proellex endometriosis ph ii (enrollment ended early (Aug 08) so results estimated by late 4Q08 or early 1Q09) RPRX - Proellex Uterine Fibroids ph iii (clinicaltrials.org expected end date is March 09) RPRX - Androxal Phase 2b in male fertility and testicular function: initiated June 2008